Compugen Ltd.: valuation
What the market value assumes, and what the company's own statements and its peers' prices would put it at. Every assumption is yours to change.
Cash-flow value and what the price assumes
Average of FY2023–FY2025 (cash from operations less capital spending), from the statements below.
Starts at revenue growth over the last three years, 113.3% a year, held within -10% to 25% (statements).
US Treasury 10-year yield on Nov 13, 2026: 5.15% (US Treasury).
Your assumption: the extra yearly return you want for holding shares rather than Treasuries. 5% is a round starting figure, not data.
Your assumption: long-run growth, usually near inflation. It must stay below the discount rate.
Debt or cash not on file: 0 to start with.
What today's price assumes
The price's implied growth cannot be worked out with these figures (it needs a positive cash flow, a market value and a discount rate above long-run growth).
Against the market value, for other rates
Cash-flow value of the shares as a percentage above or below today's market value; your inputs in the middle.
| Discount rate ↓ / growth → | 20% | 22.5% | 25% | 27.5% | 30% |
|---|---|---|---|---|---|
| 8.15% | — | — | — | — | — |
| 9.15% | — | — | — | — | — |
| 10.15% | — | — | — | — | — |
| 11.15% | — | — | — | — | — |
| 12.15% | — | — | — | — | — |
On one scale
Bars: from the 25th to the 75th percentile multiple of the peers, the line at the median; dot: the cash-flow value with your inputs.
Your own DCF model
A full discounted-cash-flow model of Compugen Ltd., started from its filings: revenue growth and margins year by year, bear, base and bull cases, the WACC and its parts, sensitivity tables and a value per share against the dated market price. Save it, share it with your team or by a read-only link.
Open the DCF modelAgainst the industry Biotechnology
Multiples of its companies with a market value at most 60 days old, times Compugen Ltd.'s own figures of FY2025.
| Multiple | Peers (25th / median / 75th) | Compugen Ltd. | Applied to | Value (25th to 75th) | Companies |
|---|---|---|---|---|---|
| P/E | 9.4× / 20.0× / 58.8× | — | net income $35 M | $333 M to $2.1 B | 34 |
| Price to sales | 2.2× / 5.0× / 10.1× | — | revenue $73 M | $163 M to $734 M | 85 |
| Price to book | 3.1× / 4.5× / 12.3× | — | book equity $103 M | $319 M to $1.3 B | 70 |
Peers' multiples from the distributions by industry; the company's figures from its statements below. A multiple says what similar companies cost, not what this one is worth.
Against its own history
Compugen Ltd.'s multiples at each month end with a market cap on file, Jan 2020 to Jan 2024, each against its own median.
Price to book
2.2×Now below its median of 2.6×; range 0.6× to 26.1× over 6 months.
as of Jan 5, 2024. Market caps: the dated values on file since 2020. Each month divides by the last twelve months' results that had been published by then (a quarter 45 days after it ended, a fiscal year 60 days after), so the past is not read with figures that came out later; months with a loss give no P/E. Newest month: Jan 5, 2024.
The statements it starts from
USD millions at each year's exchange rate; free cash flow = cash from operations less capital spending.
| Fiscal year | Revenue | Net income | Cash from operations | Capital spending | Free cash flow | Net debt | Source |
|---|---|---|---|---|---|---|---|
| FY2025to Dec 31, 2025 | $73 M | $35 M | $32 M | $0 M | $31 M | — | SEC annual report (10-K, 20-F) |
| FY2024to Dec 31, 2024 | $28 M | $-14 M | $50 M | $0 M | $49 M | — | SEC annual report (10-K, 20-F) |
| FY2023to Dec 31, 2023 | $33 M | $-19 M | $-36 M | $0 M | $-36 M | — | SEC annual report (10-K, 20-F) |
| FY2022to Dec 31, 2022 | $8 M | $-34 M | $-34 M | $0 M | $-35 M | — | SEC annual report (10-K, 20-F) |
| FY2021to Dec 31, 2021 | $6 M | $-34 M | $-23 M | $0 M | $-23 M | — | SEC annual report (10-K, 20-F) |
| FY2020to Dec 31, 2020 | $2 M | $-30 M | $-28 M | $0 M | $-28 M | — | SEC annual report (10-K, 20-F) |
Each figure as filed; the full statements with every line and its filing are on the company page. Market value not on file.
How it is worked out: the cash-flow value is free cash flow grown at the first-stage rate for the years chosen, then at the long-run rate for ever, each year discounted at the risk-free rate plus the equity risk premium, less net debt. What the price assumes is the first-stage growth that makes that value equal today's market value. The starting cash flow, growth and net debt come from the statements; the risk-free rate from the US Treasury; the premium and the long-run growth are assumptions and are labelled so. This is arithmetic on reported figures, not advice.